Skip to content

Celcuity CELC Retained Earnings

Retained Earnings at other companies

Eli Lilly logo
Eli LillyLLY
$29.51B+95.5%
Gilead Sciences logo
Gilead SciencesGILD
$14.13B+29.3%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-$3.99B-22.1%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
-$2.09B-15.0%
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
-$1.29B-38.0%
Tango Therapeutics logo
Tango TherapeuticsTNGX
-$648.67M-19.8%

Other financials

Income statement

See full
Operating income-$50.5M-39.8%
Net income-$52.8M-42.8%
EPS (diluted)-$0.97-12.8%

Balance sheet

See full
Cash & equivalents$145.2M+781%
Total debt$137.9M+30.7%
Total equity$53.5M-38.2%
Total assets$410.2M+88.0%

Cash flow

See full
Operating cash flow-$55.1M-53.6%
CapEx$249.0K+315%
Free cash flow-$55.3M-54.0%

Valuation

See full
Market cap$4.28B+1,370%
Enterprise value$4.27B+1,086%

Returns & leverage

See full
Return on equity-275.2%-990pp
Debt / equity2.6×+1.4×
Current ratio12.3×+5.7×

Where this comes from

Reported directly by Celcuity in its filing.

Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.

The official record: Celcuity’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celcuity's retained earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Celcuity's retained earnings?
Celcuity (CELC) reported retained earnings of -$501.74M in Q1 2026.
How has Celcuity's retained earnings changed year-over-year?
Celcuity's retained earnings decreased by 62.5% year-over-year, from -$308.85M to -$501.74M.
What is the long-term trend for Celcuity's retained earnings?
Over 5 years (2020 to 2025), Celcuity's retained earnings has grown at a 76.3% compound annual growth rate (CAGR), from -$26.32M to -$448.9M.
What does retained earnings mean?
Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.